Company Announcements

Illumina named Laura Lauman vice president of Marketing in December 2011. She was formerly president of AB SCIEX.

In January, Illumina appointed Marc Stapley senior vice president and CFO. Previously, he was senior vice president, Finance, at Pfizer.

The Austin Business Journal reported in December 2011 that Thermo Fisher Scientific will hire 150 people in Round Rock, Texas, as it relocates wood casework production from Wisconsin to Round Rock later this year.

Techcomp announced in December 2011 the acquisition of the remaining 32% equity interest in Richwell for CNY 7.2 million ($1.1 million) in cash. Richwell holds an 81% share in Shanghai Sanco Instrument.

In January, Thermo Fisher Scientific appointed Gregory J. Herrema, formerly president of Analytical Instruments, to president of Biosciences; Alan J. Malus, formerly president of Laboratory Products, to president of Analytical Technologies; and Thomas W. Loewald, formerly president of Laboratory Equipment, to president of Laboratory Products and executive officer.

HORIBA announced in January that it merged four US subsidiaries of HORIBA Instruments, as well as unified HORIBA ABX’s Brazilian subsidiary with its North American business to form HORIBA Instruments Brasil.

Pall announced in January that COO Roberto Perez will retire in April.

The Hartford Courant reported in January that PerkinElmer plans to terminate 75 positions in Shelton, Connecticut, due to the manufacturing relocation of four analytical product lines to Singapore and the UK.

GE reported in its fourth-quarter conference call that Life Sciences sales increased 3%.

Corning Life Sciences’ 2011 sales increased 17.1%, 7% excluding acquisitions, to $595 million. First-quarter sales are expected to increase 10%.

Lonza’s 2011 Bioscience sales fell 4.3% to CHF 202 million ($227 million) but grew 11.8% at constant exchange rates due to Cell Therapy sales. Testing Solutions sales grew 5% in local currency. Research Solutions sales declined slightly.

Hitachi High-Technologies Science & Medical Systems’ fiscal third-quarter sales ending December 31, 2011, grew 50.4% to ¥39,400 million ($509.6 million) due to sales of a new clinical analyzer and DNA sequencers. Analytical Instruments, Electron Microscopes, Clinical Analyzers, and Biotechnology Products/Others accounted for 9%, 18%, 59% and 14% of segment sales, respectively. The company increased its fiscal 2013 sales forecast for the segment by 7% to ¥142,000 million ($1,836.8 million).

In January, Life Technologies named Alan Sachs, MD, PhD, head of Global Research and Development. Previously, he was vice president of Exploratory and Translational Sciences at Merck Research Laboratories.